| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 9.75e-06 | 5 | 200 | 3 | GO:0140346 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 3.36e-05 | 7 | 200 | 3 | GO:0015247 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 7.95e-05 | 9 | 200 | 3 | GO:0090556 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1C1 ATP8A2 ATP8B1 IFIH1 MOV10L1 ACSBG2 ATP11A DNAH6 DYNC1I1 DNAH3 KIF26B DNAH1 ENTPD2 DHX32 MORC3 DDX21 SNRNP200 | 1.57e-04 | 614 | 200 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 2.97e-04 | 3 | 200 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.32e-04 | 14 | 200 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.32e-04 | 14 | 200 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 4.34e-04 | 97 | 200 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | floppase activity | 5.03e-04 | 16 | 200 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 6.07e-04 | 17 | 200 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.85e-04 | 70 | 200 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.23e-04 | 18 | 200 | 3 | GO:0008569 | |
| GeneOntologyCellularComponent | lamellipodium | ACTG2 ITGB1 FGD4 SYNE2 PLCG1 CDC42BPA WASF2 RAB3IP MTSS2 PLCE1 | 7.78e-05 | 230 | 200 | 10 | GO:0030027 |
| GeneOntologyCellularComponent | inner dynein arm | 9.85e-05 | 10 | 200 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.91e-04 | 14 | 200 | 3 | GO:1990531 | |
| Domain | A1A_glycop | 1.12e-04 | 2 | 198 | 2 | IPR001500 | |
| Domain | NLGN4 | 1.12e-04 | 2 | 198 | 2 | IPR030025 | |
| Domain | - | 1.30e-04 | 25 | 198 | 4 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.30e-04 | 25 | 198 | 4 | IPR017946 | |
| Domain | InsP3_rcpt-bd | 3.33e-04 | 3 | 198 | 2 | IPR000493 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.92e-04 | 14 | 198 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.92e-04 | 14 | 198 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.92e-04 | 14 | 198 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.92e-04 | 14 | 198 | 3 | PF08393 | |
| Domain | P_typ_ATPase_c | 3.92e-04 | 14 | 198 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.92e-04 | 14 | 198 | 3 | IPR032631 | |
| Domain | ATPase_dyneun-rel_AAA | 3.92e-04 | 14 | 198 | 3 | IPR011704 | |
| Domain | P-type_ATPase_IV | 3.92e-04 | 14 | 198 | 3 | IPR006539 | |
| Domain | MT | 3.92e-04 | 14 | 198 | 3 | PF12777 | |
| Domain | AAA_8 | 3.92e-04 | 14 | 198 | 3 | PF12780 | |
| Domain | PhoLip_ATPase_C | 3.92e-04 | 14 | 198 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.92e-04 | 14 | 198 | 3 | PF16209 | |
| Domain | AAA_5 | 3.92e-04 | 14 | 198 | 3 | PF07728 | |
| Domain | DHC_fam | 4.86e-04 | 15 | 198 | 3 | IPR026983 | |
| Domain | EF-hand_like | 4.86e-04 | 15 | 198 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 4.86e-04 | 15 | 198 | 3 | PF00387 | |
| Domain | PLCYc | 4.86e-04 | 15 | 198 | 3 | SM00149 | |
| Domain | Dynein_heavy | 4.86e-04 | 15 | 198 | 3 | PF03028 | |
| Domain | PLipase_C_Pinositol-sp_Y | 4.86e-04 | 15 | 198 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 4.86e-04 | 15 | 198 | 3 | PS50008 | |
| Domain | Dynein_heavy_dom | 4.86e-04 | 15 | 198 | 3 | IPR004273 | |
| Domain | PI-PLC_fam | 4.86e-04 | 15 | 198 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 4.86e-04 | 15 | 198 | 3 | IPR015359 | |
| Domain | Nebulin | 6.62e-04 | 4 | 198 | 2 | PF00880 | |
| Domain | NEBULIN | 6.62e-04 | 4 | 198 | 2 | PS51216 | |
| Domain | NEBU | 6.62e-04 | 4 | 198 | 2 | SM00227 | |
| Domain | Nebulin | 6.62e-04 | 4 | 198 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 6.62e-04 | 4 | 198 | 2 | IPR000900 | |
| Domain | PI-PLC-X | 8.51e-04 | 18 | 198 | 3 | PF00388 | |
| Domain | PLCXc | 8.51e-04 | 18 | 198 | 3 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 1.00e-03 | 19 | 198 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.00e-03 | 19 | 198 | 3 | IPR000909 | |
| Domain | ARM-type_fold | ITPR2 NF1 XPO5 PIK3CB DOCK1 DNAJC13 DOCK9 USP24 RIF1 PPP2R5D CSE1L | 1.02e-03 | 339 | 198 | 11 | IPR016024 |
| Domain | NIDO_dom | 1.09e-03 | 5 | 198 | 2 | IPR003886 | |
| Domain | NIDO | 1.09e-03 | 5 | 198 | 2 | SM00539 | |
| Domain | NIDO | 1.09e-03 | 5 | 198 | 2 | PF06119 | |
| Domain | NIDO | 1.09e-03 | 5 | 198 | 2 | PS51220 | |
| Domain | Nlgn | 1.09e-03 | 5 | 198 | 2 | IPR000460 | |
| Domain | RIH_assoc-dom | 1.63e-03 | 6 | 198 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.63e-03 | 6 | 198 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.63e-03 | 6 | 198 | 2 | PF08454 | |
| Domain | RIH_dom | 1.63e-03 | 6 | 198 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.63e-03 | 6 | 198 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.63e-03 | 6 | 198 | 2 | IPR015925 | |
| Domain | - | 1.63e-03 | 6 | 198 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.63e-03 | 6 | 198 | 2 | PF01365 | |
| Domain | Lag1/Lac1 | 1.63e-03 | 6 | 198 | 2 | IPR016439 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.44e-05 | 5 | 161 | 3 | M49000 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 2.51e-05 | 76 | 161 | 7 | M9052 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 5.56e-05 | 19 | 161 | 4 | M27423 | |
| Pubmed | 4.40e-09 | 24 | 202 | 6 | 10843712 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 PDE3B PTDSS1 ATP8B1 ITGB1 GALNT18 KLHL29 POGLUT1 PTPRS SUPT6H NLRC5 ATP11A PLCB4 ALCAM PLCG1 USP15 DOCK1 CYP4V2 DNAJC13 CDC42BPA NLGN4Y TECTA NXN GDE1 DNAH1 INTS6 HS2ST1 RAB3IP | 4.66e-08 | 1489 | 202 | 28 | 28611215 |
| Pubmed | BRIX1 PTDSS1 LANCL1 HMGB2 ITGB1 PM20D2 CKB POGLUT1 WDR75 XPO5 SYNE2 ATP11A PLCB4 STK25 CERS2 DNAJC13 USP24 PRPF8 LARS2 TMED4 PPP2R5D MTHFD1 CEP72 DNPEP | 6.17e-07 | 1297 | 202 | 24 | 33545068 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 11163362 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ETF1 NEB IFIH1 TRANK1 NID1 PLCB4 DOCK9 SPG11 PRPF8 KIAA0825 XIRP2 MTHFD1 DNPEP | 1.46e-06 | 497 | 202 | 14 | 36774506 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | HLCS LANCL1 HMGB2 ITGB1 CKB PYGL WDR48 CERS2 PRPF8 RIF1 INTS6 PPP2R5D CSE1L EIF3B SNRNP200 | 1.51e-06 | 573 | 202 | 15 | 28330616 |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 16627753 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USE1 PTDSS1 LANCL1 FASTKD5 ACVR1 ITGB1 PIAS3 XPO5 ALCAM CERS2 DNAJC13 SMPD4 PRPF8 GDE1 RIF1 PPP2R5D CSE1L RRN3 MORC3 SNRNP200 CXADR RNF111 | 2.27e-06 | 1203 | 202 | 22 | 29180619 |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.65e-06 | 104 | 202 | 7 | 36055981 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | ITPR2 MED24 PIAS3 WDR75 MOCS1 INTS6 CSE1L MTHFD1 MORC3 RNF111 | 3.47e-06 | 262 | 202 | 10 | 36880596 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | ETF1 ACVR1 SMYD4 ATP11A PLCB4 DOCK1 DNAJC13 NXN RIF1 INTS6 MTHFD1 WASF2 RAB3IP DHX32 | 3.49e-06 | 536 | 202 | 14 | 15840001 |
| Pubmed | ETF1 ACVR1 SMYD4 ATP11A PLCB4 DOCK1 DNAJC13 NXN RIF1 INTS6 MTHFD1 WASF2 RAB3IP DHX32 | 3.65e-06 | 538 | 202 | 14 | 10512203 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 23555611 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 20889506 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 3.81e-06 | 6 | 202 | 3 | 21762810 | |
| Pubmed | ARID4B LANCL1 NEB HSPA12B ITPR3 NF1 WDR75 SYNE2 NXF5 USP24 IL1RAPL1 OSBP CEP72 SEC23IP PAXIP1 | 5.55e-06 | 638 | 202 | 15 | 31182584 | |
| Pubmed | BRIX1 ETF1 WDR75 XPO5 SUPT6H DNAJC13 USP24 PRPF8 RIF1 CSE1L MTHFD1 SEC23IP EIF3B DDX21 SNRNP200 | 5.55e-06 | 638 | 202 | 15 | 33239621 | |
| Pubmed | BRIX1 PDE3B USE1 PTDSS1 FASTKD5 HSPA12B ITGB1 ITPR2 ITPR3 PM20D2 WDR75 SUPT6H SYNE2 DNAJC13 TMEM186 CDC42BPA SMPD4 SPG11 PRPF8 TBC1D17 PPP2R5D DDX21 SNRNP200 CXADR | 6.47e-06 | 1487 | 202 | 24 | 33957083 | |
| Pubmed | FBXW10B ATP8A2 ACVR1 SULT1B1 KCNH1 CCL14 MMP15 USP15 STK25 FBXW10 CDC42BPA GRK7 USP24 MTHFD1 ENTPD2 PRKCD | 6.49e-06 | 730 | 202 | 16 | 34857952 | |
| Pubmed | Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. | 6.64e-06 | 7 | 202 | 3 | 7477352 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 9214635 | ||
| Pubmed | BRIX1 ITPR3 CKB NF1 WDR75 XPO5 SUPT6H SYNE2 PYGL USP24 PRPF8 RIF1 CSE1L DDX21 SNRNP200 | 7.32e-06 | 653 | 202 | 15 | 22586326 | |
| Pubmed | PTDSS1 FASTKD5 ITGB1 NF1 XPO5 USP15 CERS2 SMPD4 PRPF8 RIF1 CSE1L HS2ST1 EIF3B DDX21 SNRNP200 | 7.87e-06 | 657 | 202 | 15 | 36180527 | |
| Pubmed | 7.91e-06 | 47 | 202 | 5 | 8812413 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PTDSS1 NUF2 RTKN NF1 XPO5 MIOS PYGL USP15 WDR48 DNAJC13 PRPF8 NXN TMED4 RIF1 PPP2R5D CSE1L RAB3IP SEC23IP MORC3 SNRNP200 ANKS3 DNPEP | 9.96e-06 | 1321 | 202 | 22 | 27173435 |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 1.06e-05 | 8 | 202 | 3 | 18703590 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | PDE3B USE1 PTDSS1 ITGB1 ITPR2 ITPR3 SYNE2 SMPD4 PRPF8 DDX21 SNRNP200 | 1.37e-05 | 375 | 202 | 11 | 32788342 |
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 22889924 | ||
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 7589147 | ||
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 10501179 | ||
| Pubmed | 1.75e-05 | 27 | 202 | 4 | 20336759 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.57e-05 | 202 | 202 | 8 | 33005030 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CEP85L ETF1 CKB WDR75 SUPT6H KLHL13 MIOS PYGL USP15 STK25 WDR48 CNKSR2 PRPF8 NXN CSE1L RRN3 EIF3B SNRNP200 | 2.60e-05 | 1005 | 202 | 18 | 19615732 |
| Pubmed | FASTKD5 MED24 WDR75 XPO5 SUPT6H PRPF8 INTS6 PPP2R5D CSE1L WASF2 HS2ST1 SEC23IP SNRNP200 | 2.70e-05 | 560 | 202 | 13 | 35241646 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | BRIX1 RGS22 ETF1 LANCL1 FASTKD5 CKB NF1 WDR75 XPO5 SUPT6H PLCG1 TDRD6 PRPF8 RIF1 CSE1L MTHFD1 SEC23IP PRKCD EIF3B DDX21 SNRNP200 DNPEP | 3.16e-05 | 1425 | 202 | 22 | 30948266 |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 15253437 | ||
| Pubmed | Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants. | 3.36e-05 | 2 | 202 | 2 | 16290938 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 15157739 | ||
| Pubmed | Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis. | 3.36e-05 | 2 | 202 | 2 | 37949310 | |
| Pubmed | Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF. | 3.36e-05 | 2 | 202 | 2 | 17987628 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 1973682 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26398595 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 9524265 | ||
| Pubmed | Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes. | 3.36e-05 | 2 | 202 | 2 | 28927749 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 21791597 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 22415874 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 4711474 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 25264156 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23183221 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 3.36e-05 | 2 | 202 | 2 | 8081734 | |
| Pubmed | Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients. | 3.36e-05 | 2 | 202 | 2 | 25408356 | |
| Pubmed | Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1. | 3.36e-05 | 2 | 202 | 2 | 3676251 | |
| Pubmed | Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene. | 3.36e-05 | 2 | 202 | 2 | 2970990 | |
| Pubmed | PKCdelta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant. | 3.36e-05 | 2 | 202 | 2 | 15542581 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 3375073 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 4603214 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 11773052 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 12004082 | ||
| Pubmed | A mouse gene family associated with a major submaxillary-gland glycoprotein. | 3.36e-05 | 2 | 202 | 2 | 3977853 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 29087248 | ||
| Pubmed | Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3). | 3.36e-05 | 2 | 202 | 2 | 1605854 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20119835 | ||
| Pubmed | Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells. | 3.36e-05 | 2 | 202 | 2 | 12393498 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 3.36e-05 | 2 | 202 | 2 | 17496801 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 33674626 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 24515435 | ||
| Pubmed | Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse. | 3.36e-05 | 2 | 202 | 2 | 3003086 | |
| Pubmed | Structure of human alpha1-acid glycoprotein and its high-affinity binding site. | 3.36e-05 | 2 | 202 | 2 | 12480518 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 18434543 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 3.36e-05 | 2 | 202 | 2 | 31400758 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 21638284 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 19528657 | ||
| Pubmed | Identification and characterization of stem cells in prepubertal spermatogenesis in mice. | 3.36e-05 | 2 | 202 | 2 | 12781694 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 8063813 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 22821963 | ||
| Pubmed | SOX13 dependent PAX8 expression promotes the proliferation of gastric carcinoma cells. | 3.36e-05 | 2 | 202 | 2 | 31353958 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 3.36e-05 | 2 | 202 | 2 | 37080762 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 38605034 | ||
| Pubmed | Allelic differences in TCR gamma-chains alter gamma delta T cell antigen reactivity. | 3.36e-05 | 2 | 202 | 2 | 8046225 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 29106499 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20811680 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 37450367 | ||
| Pubmed | Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. | 3.36e-05 | 2 | 202 | 2 | 1714377 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 3.36e-05 | 2 | 202 | 2 | 24104404 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 32651445 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20617306 | ||
| Pubmed | Physical linkage of mouse Tcrg-V genes. II. Regulatory features of the Vg4-Vg3 intergenic region. | 3.36e-05 | 2 | 202 | 2 | 8119740 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 21883169 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 22989184 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 31914407 | ||
| Pubmed | CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. | 3.36e-05 | 2 | 202 | 2 | 16857986 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 33037075 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 24389491 | ||
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 3.36e-05 | 2 | 202 | 2 | 9065779 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 34210751 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 37640741 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 21670278 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 3486244 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 33846468 | ||
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.85e-04 | 3 | 143 | 2 | 297 | |
| GeneFamily | ATPase phospholipid transporting | 2.06e-04 | 15 | 143 | 3 | 1210 | |
| GeneFamily | Dyneins, axonemal | 3.04e-04 | 17 | 143 | 3 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.28e-04 | 19 | 143 | 3 | 832 | |
| GeneFamily | CERS class homeoboxes | 9.13e-04 | 6 | 143 | 2 | 530 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL10RB SIGLEC9 ITGB1 TNFRSF21 PTPRC CCR7 ALCAM KIT TLR2 LY75 | 1.18e-03 | 394 | 143 | 10 | 471 |
| GeneFamily | Exportins | 1.27e-03 | 7 | 143 | 2 | 547 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.27e-03 | 206 | 143 | 7 | 682 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.26e-03 | 11 | 143 | 2 | 1168 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 3.26e-03 | 11 | 143 | 2 | 559 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 3.89e-03 | 12 | 143 | 2 | 670 | |
| GeneFamily | Kelch like|BTB domain containing | 4.44e-03 | 42 | 143 | 3 | 617 | |
| GeneFamily | Phospholipases | 4.44e-03 | 42 | 143 | 3 | 467 | |
| GeneFamily | Sterile alpha motif domain containing | 5.24e-03 | 88 | 143 | 4 | 760 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BRIX1 BDP1 ARID4B NUF2 ITGB1 FAM13B ITPR2 IFIH1 SYNE2 NID1 TRPM1 KIT DYNC1I1 DNAJC13 CDC42BPA SPG11 TDRD7 RIF1 MOXD1 DDX21 | 1.99e-07 | 656 | 202 | 20 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATP8B1 ACVR1 ST3GAL5 SYNE2 PLCB4 ALCAM USP15 DOCK1 DNAJC13 CDC42BPA DOCK9 USP24 CHSY1 SPG11 LARS2 ATF2 TDRD7 PIKFYVE RIF1 CSE1L DDX21 PLCE1 | 8.60e-07 | 856 | 202 | 22 | M4500 |
| Coexpression | GSE27786_LSK_VS_MONO_MAC_DN | 2.66e-05 | 200 | 202 | 9 | M4765 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 2.66e-05 | 200 | 202 | 9 | M5030 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | PDE3B SLC6A19 ITPR2 WDR75 NLRC5 CCR7 PLCG1 USP24 RIF1 TCP11L2 SLC15A2 RAB3IP LY75 | 1.39e-05 | 336 | 194 | 13 | GSM538413_500 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDE3B ATP8B1 GALNT18 PLCB4 KIT DOCK1 DOCK9 NXN KIAA0825 L3MBTL4 | 2.14e-08 | 194 | 202 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 181 | 202 | 9 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-07 | 192 | 202 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-07 | 193 | 202 | 9 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.58e-07 | 193 | 202 | 9 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-07 | 193 | 202 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 166 | 202 | 8 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 166 | 202 | 8 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 171 | 202 | 8 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 171 | 202 | 8 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 172 | 202 | 8 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.66e-06 | 179 | 202 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-06 | 188 | 202 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-06 | 188 | 202 | 8 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.49e-06 | 189 | 202 | 8 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 190 | 202 | 8 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-06 | 191 | 202 | 8 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-06 | 191 | 202 | 8 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-06 | 191 | 202 | 8 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.91e-06 | 193 | 202 | 8 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.91e-06 | 193 | 202 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 3.03e-06 | 194 | 202 | 8 | b45f1e80074a19245bc5dc4b3a583419a1904404 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.15e-06 | 195 | 202 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.15e-06 | 195 | 202 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.15e-06 | 195 | 202 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.27e-06 | 138 | 202 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 197 | 202 | 8 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.39e-06 | 197 | 202 | 8 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.39e-06 | 197 | 202 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-06 | 197 | 202 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 199 | 202 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.65e-06 | 199 | 202 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.79e-06 | 200 | 202 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-06 | 200 | 202 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-06 | 200 | 202 | 8 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-06 | 200 | 202 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.79e-06 | 200 | 202 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.92e-06 | 151 | 202 | 7 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-06 | 160 | 202 | 7 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-05 | 168 | 202 | 7 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.28e-05 | 170 | 202 | 7 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 171 | 202 | 7 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 173 | 202 | 7 | e3cb7c8c09f937da6b8d673e9adfec5d94a15548 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.61e-05 | 176 | 202 | 7 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.61e-05 | 176 | 202 | 7 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 177 | 202 | 7 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 1.73e-05 | 178 | 202 | 7 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 178 | 202 | 7 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 178 | 202 | 7 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 179 | 202 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 179 | 202 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 180 | 202 | 7 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.99e-05 | 182 | 202 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.07e-05 | 183 | 202 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 184 | 202 | 7 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.14e-05 | 184 | 202 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-05 | 185 | 202 | 7 | fd51fef8c69e34c72017d8371ab0a0d7be5701f2 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-05 | 185 | 202 | 7 | bea26e369ae91006052b973cd89b4c49afa9e553 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-05 | 185 | 202 | 7 | 2adb32096aa3473f8d417e5ce9e65264beca9b52 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-05 | 185 | 202 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.22e-05 | 185 | 202 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 186 | 202 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 187 | 202 | 7 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 187 | 202 | 7 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 187 | 202 | 7 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 187 | 202 | 7 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 188 | 202 | 7 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 188 | 202 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 202 | 7 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 202 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 189 | 202 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.54e-05 | 189 | 202 | 7 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.54e-05 | 189 | 202 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.54e-05 | 189 | 202 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND10-Epithelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 189 | 202 | 7 | 89349e226a5512833a94b1bf68056a6985fe4afd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.63e-05 | 190 | 202 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | E18.5-samps-Epithelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.63e-05 | 190 | 202 | 7 | 90accc078e9a72329a415d5cefe062c4196bb624 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | ee39fb88f31d2d65b5d3e7416db68f5df07f6637 | |
| ToppCell | PND14-Epithelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | 33d1b0a38267270e87702ba5794f07233acf4955 | |
| ToppCell | PND07-Epithelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | e3a2c8b637f60c963520dffe99c526809d818cab | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.63e-05 | 190 | 202 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-05 | 191 | 202 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 191 | 202 | 7 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 191 | 202 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-05 | 191 | 202 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-05 | 191 | 202 | 7 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-05 | 191 | 202 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-05 | 192 | 202 | 7 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-05 | 192 | 202 | 7 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| Drug | orthovanadate | ATP6V1C1 RFK PDE3B ATP8B1 PTPRC PTPRS PIK3CB PYGL PLCG1 DNAH3 DNAH1 PIKFYVE ENTPD2 SEC23IP PRKCD | 8.07e-06 | 435 | 201 | 15 | CID000061672 |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | RFK HLCS ITPR2 NF1 ST3GAL5 PTPRS NID1 CDC42BPA SOX13 SEC23IP | 8.84e-06 | 193 | 201 | 10 | 1480_UP |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 201 | 10 | 5393_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 1.30e-05 | 160 | 201 | 9 | 6133_DN | |
| Drug | AC1OAGGW | ACTG2 ITPR3 PIK3CB PLCB4 PLCG1 PIKFYVE IL1RAPL1 OSBP SEC23IP PRKCD | 1.37e-05 | 203 | 201 | 10 | CID006857364 |
| Disease | Malignant neoplasm of breast | CEP85L TRPC4 LRRC37A2 HLCS ATP8B1 ACVR1 PKDREJ NF1 CLCN1 PTPRC PIK3CB KCNH1 SYNE2 NLRC5 KIT C1orf87 TECTA ATF2 EPG5 CRX RIF1 DHX32 | 3.07e-06 | 1074 | 196 | 22 | C0006142 |
| Disease | phenylacetylglutamate measurement | 4.39e-05 | 2 | 196 | 2 | EFO_0800687 | |
| Disease | X-21364 measurement | 1.31e-04 | 3 | 196 | 2 | EFO_0800811 | |
| Disease | TYPE 1 DIABETES MELLITUS | 2.61e-04 | 4 | 196 | 2 | 222100 | |
| Disease | Diabetes mellitus type 1 | 2.61e-04 | 4 | 196 | 2 | cv:C0011854 | |
| Disease | Colorectal Carcinoma | NF1 NLGN4X PAX8 PTPRS NID1 DNAH3 CNKSR2 NXN OSBP CSE1L GUCY2C TLR2 TNS4 SNRNP200 | 2.71e-04 | 702 | 196 | 14 | C0009402 |
| Disease | suberoylcarnitine (C8-DC) measurement | 4.33e-04 | 5 | 196 | 2 | EFO_0800382 | |
| Disease | X-12798 measurement | 4.33e-04 | 5 | 196 | 2 | EFO_0021335 | |
| Disease | neuropeptide W measurement | 6.47e-04 | 6 | 196 | 2 | EFO_0801835 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 6.47e-04 | 6 | 196 | 2 | EFO_0802054 | |
| Disease | platelet crit | ARID4B FAM13B PANK1 ITPR2 KLHL29 NF1 PTPRC USP15 KIT DNAH3 NXN EPG5 INSL6 SLC15A2 LY75 PLCE1 | 6.59e-04 | 952 | 196 | 16 | EFO_0007985 |
| Disease | blood rubidium measurement | 6.70e-04 | 26 | 196 | 3 | EFO_0021529 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 7.51e-04 | 27 | 196 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.70e-04 | 291 | 196 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | 21-hydroxypregnenolone disulfate measurement | 9.02e-04 | 7 | 196 | 2 | EFO_0800281 | |
| Disease | aspartate aminotransferase measurement | BDP1 ATP8B1 PTCH1 CKB NF1 PTPRC NLRC5 MMP15 CERS2 HNF1A DNAJC13 SERPINA2 LY75 ACOXL PLCE1 | 1.10e-03 | 904 | 196 | 15 | EFO_0004736 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.31e-03 | 121 | 196 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0800278 | |
| Disease | Glaucoma | 1.53e-03 | 9 | 196 | 2 | C0017601 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.62e-03 | 127 | 196 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | unipolar depression, alcohol dependence | 1.84e-03 | 78 | 196 | 4 | EFO_0003761, MONDO_0007079 | |
| Disease | heart disease (implicated_via_orthology) | 2.05e-03 | 38 | 196 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.32e-03 | 11 | 196 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | coagulation factor XA measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0020266 | |
| Disease | N-acetylphenylalanine measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0800019 | |
| Disease | N-acetylhistidine measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0800022 | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0800279 | |
| Disease | retinal vasculature measurement | SOX5 KLHL29 MOCS1 CDC42BPA CSE1L XIRP2 ELP4 ACOXL L3MBTL4 PLCE1 | 2.52e-03 | 517 | 196 | 10 | EFO_0010554 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.77e-03 | 12 | 196 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.77e-03 | 12 | 196 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.77e-03 | 12 | 196 | 2 | C3160718 | |
| Disease | N-delta-acetylornithine measurement | 2.77e-03 | 12 | 196 | 2 | EFO_0800067 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 2.77e-03 | 12 | 196 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | Disorder of eye | 3.02e-03 | 212 | 196 | 6 | C0015397 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.22e-03 | 91 | 196 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | 3-formylindole measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0801025 | |
| Disease | coagulation factor X measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0020265 | |
| Disease | male infertility (implicated_via_orthology) | 3.26e-03 | 13 | 196 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | X-19141 measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0800799 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.34e-03 | 150 | 196 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.54e-03 | 152 | 196 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.78e-03 | 47 | 196 | 3 | C3179349 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.78e-03 | 222 | 196 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | X-21470 measurement | 3.79e-03 | 14 | 196 | 2 | EFO_0800817 | |
| Disease | iron biomarker measurement | 4.01e-03 | 48 | 196 | 3 | EFO_0004461 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.04e-03 | 225 | 196 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | colorectal cancer (is_marker_for) | 4.06e-03 | 157 | 196 | 5 | DOID:9256 (is_marker_for) | |
| Disease | phospholipids:total lipids ratio | 4.22e-03 | 227 | 196 | 6 | EFO_0020946 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.35e-03 | 99 | 196 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | mannan-binding lectin serine protease 1 measurement | 4.35e-03 | 15 | 196 | 2 | EFO_0008223 | |
| Disease | Gastrointestinal Stromal Tumors | 4.50e-03 | 50 | 196 | 3 | C0238198 | |
| Disease | Vitiligo | 4.67e-03 | 101 | 196 | 4 | EFO_0004208 | |
| Disease | colorectal mucinous adenocarcinoma | 4.95e-03 | 16 | 196 | 2 | EFO_0009361 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 5.00e-03 | 103 | 196 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Retinitis Pigmentosa | 5.18e-03 | 104 | 196 | 4 | C0035334 | |
| Disease | lipoprotein measurement | 5.36e-03 | 105 | 196 | 4 | EFO_0004732 | |
| Disease | Metastatic melanoma | 5.58e-03 | 54 | 196 | 3 | C0278883 | |
| Disease | Astrocytosis | 5.59e-03 | 17 | 196 | 2 | C3887640 | |
| Disease | esophageal carcinoma, gastric carcinoma | 5.59e-03 | 17 | 196 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | sphingomyelin 14:0 measurement | 5.59e-03 | 17 | 196 | 2 | EFO_0010390 | |
| Disease | Gliosis | 5.59e-03 | 17 | 196 | 2 | C0017639 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 5.59e-03 | 17 | 196 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | phospholipids in medium HDL measurement | 5.88e-03 | 55 | 196 | 3 | EFO_0022295 | |
| Disease | pancreatic carcinoma | 6.24e-03 | 174 | 196 | 5 | EFO_0002618 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 6.30e-03 | 110 | 196 | 4 | EFO_0803335 | |
| Disease | melanoma | 6.44e-03 | 248 | 196 | 6 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPMKKNNNLYSWDDF | 186 | Q5FVE4 | |
| LPKVYKWSFQMSDLE | 1211 | Q4LE39 | |
| LFSKWSPYMADVKTF | 1916 | Q9HCE0 | |
| KNYYSKPWSNKETDM | 296 | A6H8Y1 | |
| KYMTISDEWDIPEKQ | 271 | P55884 | |
| MNKDYQKFWSSPSDP | 1 | Q8TC20 | |
| WNIKPESKYFMTRNS | 66 | Q9ULA0 | |
| QKMKEILYWFANSTQ | 116 | Q5XX13 | |
| KTLMFGSYLDDEKNW | 126 | P19652 | |
| AKLMKECWYQNPSAR | 471 | Q04771 | |
| KDVRNFKAWFLPIMY | 51 | P32248 | |
| MFPALYRNSKSHWNK | 446 | Q14738 | |
| KKKQDLYMWLSNSPH | 121 | Q8TDN6 | |
| STFQQMWISKPEYDE | 351 | P63267 | |
| RQYKDLWNMSDDKPF | 11 | P15336 | |
| HWSYQELKKTMALFP | 621 | Q9P209 | |
| DLPIWKEKYSFMENL | 61 | Q7L7V1 | |
| LESAKMFNYAGWKNT | 246 | Q96G23 | |
| NWYIKKMDTTSDNFG | 346 | Q9NTI2 | |
| WDLQMYYAEKDTPAK | 421 | O43520 | |
| KWFQPLQEQKYTGMF | 76 | Q9NUZ1 | |
| SPEMVNYEKLLWFLN | 246 | Q8N0U7 | |
| NTEKLWELSPANYMK | 136 | O75901 | |
| KIGDYKRQNPTMFAW | 91 | Q06710 | |
| SLYNEFRLWKDEPTM | 316 | Q96QF0 | |
| TTYWLTGMKDQKFNL | 996 | P25092 | |
| LKWRQSFESYLKTMP | 406 | Q9UL03 | |
| MNAKWDTGENPIYKS | 771 | P05556 | |
| CPMNRYSAQKQYWKA | 61 | Q14571 | |
| PMNRYSAQKQYWKAK | 61 | Q14573 | |
| AFYNSKAKRWMALPD | 296 | Q0D2K2 | |
| QKMKEILYWFANSTQ | 116 | O95170 | |
| YPEQMSDKQLLATWK | 616 | Q6ZW49 | |
| LVDAEYTKNQAWKSM | 231 | Q8NBL1 | |
| NMSNYKEKFSTLLWL | 526 | Q9BXT6 | |
| LESMPKEWNYSPKET | 941 | Q8IV33 | |
| LSSFGQPLWFKDMYK | 1641 | A6NM11 | |
| KRNFTAKSPLMYEWY | 196 | O43813 | |
| MNRTFTDKWEDYPKS | 351 | P10721 | |
| VLPEDMKTQWAKKAY | 661 | Q86VF7 | |
| ETLFKSKDYEFMWNP | 261 | P12277 | |
| QKKPTMYPEWKSTFD | 46 | Q05655 | |
| EMWSEQSAKDKQPYE | 131 | P26583 | |
| DMLYAQKAKGWQLTQ | 111 | P0DMR3 | |
| KQYLMLDPNKWLSEF | 2046 | Q2KJY2 | |
| IMAPFYQWKDVDNFK | 276 | P51511 | |
| SYSDIAANPKVLKWM | 596 | Q9NYF5 | |
| VKWPNDIYYSDLMKI | 566 | P50747 | |
| ALVWNMKFKKTTPEY | 321 | O14576 | |
| TSMFIYKWPADKEND | 51 | Q9Y5L3 | |
| KLNSKFWKRLQYEMP | 546 | Q9NZN1 | |
| YWNEMKVKKNTEYPL | 381 | Q14149 | |
| QDENMRKWFKVTIPY | 6 | Q9H1B4 | |
| FLWQYKSSADKMQQL | 141 | Q9BZD4 | |
| DMKSSYPIWEDFNSK | 21 | Q765P7 | |
| EYDSLIEKMSNWNFP | 666 | Q13370 | |
| KNLYFTDWKMNSVVA | 1161 | P14543 | |
| PIQDSWSLVSYMDKK | 291 | Q8IXT1 | |
| VCSFLQYMEKSKPWQ | 646 | Q96M96 | |
| MIDYNPLEKKLFAWD | 476 | Q99972 | |
| EILMYKKNRTPVWFF | 96 | O95259 | |
| ITYRNKSLMWFDKTP | 1316 | O60449 | |
| DPWRVAKMVKSYLQQ | 111 | P20823 | |
| VWMDYLKACKLQNAP | 161 | Q8NA19 | |
| IYFLMHKNPKVQLWS | 116 | Q86XA0 | |
| TNPSDKWVQDYIKDM | 76 | Q16627 | |
| WKTVLSLQDKYPMAQ | 206 | Q9BXC1 | |
| WKQPAKQFMREAAYL | 211 | Q96MM6 | |
| YKPNYSLNLWSIMKN | 411 | P22059 | |
| KPNYSLNLWSIMKNC | 516 | Q969R2 | |
| VYTPWSNLKKTADMD | 91 | Q86WR0 | |
| EWLNAKMKFFLPNTD | 26 | Q86WI3 | |
| IEYMPFDGNKWNFKK | 246 | Q9NZB8 | |
| SEKWAPFVQENLLMY | 466 | Q9NXE4 | |
| MKTSVLLSWEFPDNY | 1046 | Q13332 | |
| MLKIRQKSSDPYVFW | 161 | Q96QZ0 | |
| KFMYTDWADKENPET | 421 | Q8NFZ3 | |
| YWSPLLNKEFKEMEN | 1086 | Q9Y2I7 | |
| MVKEFQPYLDLWTTA | 1016 | Q9P2D7 | |
| ITSDTNKKWYMFDGP | 1936 | Q9P2D7 | |
| EKAWSKYQTVMFNRP | 381 | P20848 | |
| ETYINPQKWEGYSKM | 3451 | Q9C0G6 | |
| WYLAEKDMNSKPEFL | 546 | Q7L8L6 | |
| MQKDFVSPAYLKKWS | 276 | Q9NZC3 | |
| PRYNKWMQVASLNEK | 416 | Q9P2N7 | |
| MFKNLIGKNVYPFDW | 971 | Q14185 | |
| LKSMSDDALFTYWNK | 1311 | Q9BZ29 | |
| AMLKNKVPYEQLWST | 861 | Q8TD57 | |
| YEDTVTSKPWKMNLS | 136 | O60609 | |
| LQYEWQKLSDSQKMP | 171 | P78310 | |
| QPYEQWAIQMEKKAA | 576 | Q9BYX4 | |
| DEFKSHVYMAWNIPQ | 411 | Q6P9A2 | |
| SPGYQDFSKWESMLK | 351 | Q5SZL2 | |
| AAKMPESAWKFLFYL | 96 | P27544 | |
| KQIDKSSMYKFLEPW | 116 | Q6ZWL3 | |
| IAMDQYGKFNKVPEW | 686 | O75165 | |
| FLAPKIENEYETWTM | 131 | Q08334 | |
| PYESQEKMKVQDSWV | 311 | Q9UI17 | |
| KTYMLAFDVNDEKNW | 126 | P02763 | |
| QAKSYMKTKNPDSQW | 386 | Q6ZW76 | |
| SYLEMKRFVQWLKPQ | 996 | Q6PJP8 | |
| TPESNIKMKIAWRYQ | 151 | Q96EB1 | |
| EMPNISYAWKELKEQ | 646 | Q9NR30 | |
| FYDKFLQWKLFEMQP | 171 | Q8WTQ7 | |
| LQWKLFEMQPVSDKY | 176 | Q8WTQ7 | |
| LDWAAEKYPKQLIMD | 281 | Q16348 | |
| QGYWNETLKEFKAMA | 86 | Q9Y2C5 | |
| DVPQNLMFGKWKYEK | 46 | Q13740 | |
| MTKANGKYWPIDNFD | 2846 | Q6ZTR5 | |
| KFMYTDWADKENPET | 421 | Q8N0W4 | |
| EKFKPGKWMIQYNNL | 296 | P11586 | |
| WMLFNLAKYPEYQEK | 346 | Q6NT55 | |
| NPMDPLDYKDQSAWK | 281 | O43186 | |
| DVMNYFAWEKNPSTI | 126 | Q6UW15 | |
| YAMDFWSKGQLKALF | 561 | Q8TE04 | |
| FDLMIKENPSSQYWK | 86 | O75496 | |
| LRIPLMWKDTEYFKN | 126 | Q9BST9 | |
| KKFIDPIYQVWEDMS | 571 | Q9NYV6 | |
| QWDMAKYPIKQSLKN | 106 | P21283 | |
| SRPKWDNKAQYMLTC | 31 | Q695T7 | |
| MDLPVDEWKSYLLQK | 1 | Q8IYR2 | |
| DTSVFLNWYNPEKKM | 1506 | O60522 | |
| MAKPYEFNWQKEVPS | 1 | Q15147 | |
| KSMTPTQNREKWIYY | 396 | O75509 | |
| NDTYMKFSWLTVPEK | 66 | P0CF51 | |
| NDTYMKFSWLTVPEE | 66 | P03986 | |
| WDYQKKELPETLMTD | 311 | Q8N4U5 | |
| FIEFNAKKMWPQYCQ | 4401 | Q8WXH0 | |
| WFIKTTAYAKAMQDA | 241 | Q15031 | |
| ESFKQYFSEMPWLAV | 241 | Q6DKJ4 | |
| QWMEYFKASINTLKS | 356 | Q6UWF7 | |
| WDKNCPMYQKFSPLE | 1846 | Q9P212 | |
| LEPWTKMVKSDQIAY | 771 | Q8NE09 | |
| FMSKNETYVLKLWPL | 241 | Q5UIP0 | |
| NSWEMQSLPEYKDKK | 106 | Q9Y581 | |
| TPNFNMYVKKVEKWG | 856 | Q9NTG1 | |
| TKKLLDNIKNPMYNW | 61 | Q14916 | |
| KNITSWKEMKPGFYH | 126 | Q7LGA3 | |
| YQWAINMKKFFPKGA | 21 | O75448 | |
| ENKQLPKMWLHYFRD | 836 | Q13635 | |
| SDWETGKIMPNNYKN | 861 | Q13635 | |
| LQYASLSFQMVKPWD | 431 | Q9Y336 | |
| FNWLQAMVKKETLPF | 271 | Q9UNP4 | |
| YKQLWMPFSVFDSLN | 281 | Q9Y6Y8 | |
| LWASALPKAFEEMYK | 356 | Q8NHU6 | |
| SKMKPLWLVYNNKVF | 781 | P42338 | |
| YLEWAKPFTSKVKQM | 56 | Q5VT25 | |
| NVLPNKSLWKAYMEN | 316 | Q8IYS1 | |
| WMAPEVIKQSAYDFK | 181 | O00506 | |
| PKSFWENNCKMIYLA | 116 | O43704 | |
| KEKPLFNWMETFYLL | 451 | Q9BVK2 | |
| LYSFFNGKWMQISKL | 556 | Q8N957 | |
| QLAEMWLEKNDPSYS | 776 | Q86X52 | |
| KSLQAYKWSYAQMQP | 141 | P35523 | |
| LTSKEFQQWKQMYLD | 981 | Q8WXI2 | |
| NTVLKYMWQSEPFRD | 311 | P98196 | |
| AALYLQMNEKKPTWT | 351 | Q9Y6X2 | |
| EPQMVLFNLYDDWLK | 1911 | Q6P2Q9 | |
| LMDRNNEWKLPKDTY | 1286 | Q7KZ85 | |
| YINELRTFMIKFPWK | 646 | Q96JI7 | |
| ELMYPFWQNDTKTPK | 26 | O75443 | |
| WLFETQPMESLYEKV | 921 | A4UGR9 | |
| YSWKVDFLKGMLQAE | 61 | Q9NZ43 | |
| YMDEGNDPKIFWKNL | 346 | Q4W5G0 | |
| EYFRMKLQWKSVSPE | 346 | Q9HA65 | |
| RWKSMTNQEKQPYYE | 461 | Q9UN79 | |
| SMLQEYAKNPSVNWK | 411 | P55060 | |
| AKIYWNLENYPMVEK | 431 | Q8N4P2 | |
| FKMVYVPNWFSVDLK | 411 | Q8TAF3 | |
| PQLKSLWYTLHFMKQ | 421 | Q9NXC5 | |
| IPNKDTTYWCQMFKI | 196 | Q6UVY6 | |
| MSQWTPEYNELYTLK | 1 | Q6ZNA4 | |
| VPKNDDMWYHLFKVS | 146 | Q9NYW1 | |
| FVMDTSKYWFKPNIT | 441 | Q8IZW8 | |
| LWMYNKKTQGFILNT | 421 | Q8IWA0 | |
| KNMKRDSWVPSKYQF | 41 | Q7Z6K1 | |
| EKLPNAETEKFWMFY | 46 | Q96B77 | |
| KTSFQMAGEWLKYQL | 456 | Q9HAV4 | |
| IPDEKETRLWNKYMS | 171 | Q9Y4E8 | |
| ETRLWNKYMSNTFEP | 176 | Q9Y4E8 | |
| KLEVALYMFLWNPDT | 686 | P21359 | |
| SAMIPQFDWLGYIKK | 306 | P78562 | |
| KKQLWFPSNYVEEMV | 836 | P19174 | |
| GWNPYYKNTKKSMET | 66 | Q969G6 | |
| WKSDYPMTDGQLRSK | 36 | Q9HAC8 | |
| TDPSYFFDLWKEKML | 151 | Q9Y6W5 | |
| EEKPSWKLARNIFYM | 991 | Q7Z4N2 | |
| ENMPKFDSLWDYDVK | 101 | Q86XU0 | |
| QAMWSKDSYLKQLPH | 1951 | O75643 | |
| YRTQMWDKQKEVFLP | 56 | Q7Z7H5 | |
| LQKKMSEHYWTPQSN | 2531 | Q9UPU5 | |
| LFWTIKYEFPQKMVT | 386 | Q6ZT12 | |
| AKIYWNLENYPMVEK | 431 | Q86WT1 | |
| GSRWKAMTNLEKQPY | 591 | P35711 | |
| PYLADMNWDAVFKKA | 281 | Q9NY57 | |
| YVTFEVFKNEIWPKM | 1276 | O15050 | |
| PFVQKLWEQYMDEKD | 551 | Q2TAA8 | |
| DKVSQLYMNPKAWNT | 786 | P06737 | |
| TCQWPEKMKYLNLSS | 431 | O60603 | |
| KYINASFIMSYWKPE | 1016 | P08575 | |
| LNFEQVKSLMYWLDP | 121 | P48651 | |
| ENKEKTMEFWKGYPN | 51 | Q9BZD7 | |
| KSLRNLKYKNFMPWQ | 126 | Q9UL59 | |
| LKYKNFMPWQSLETK | 131 | Q9UL59 | |
| FMPWQSLETKTTQDY | 136 | Q9UL59 | |
| FVKYSALNPRESWDM | 456 | Q9UBN4 | |
| WDQRTIMKPLEYQFK | 446 | Q9H808 | |
| SMPLLEWFANNYKKF | 371 | P62495 | |
| NTWSFIESPMIDNKY | 756 | Q96CT2 | |
| SDNLYKSDFTNWMKG | 1676 | P20929 |